Published in Am J Cardiol on December 19, 2012
Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circ Res (2015) 1.20
No Obesity Paradox-BMI Incapable of Adequately Capturing the Relation of Obesity with All-Cause Mortality: An Inception Diabetes Cohort Study. Int J Endocrinol (2014) 0.80
The Accuracy of Body Mass Index and Gallagher's Classification in Detecting Obesity among Iranians. Iran J Med Sci (2016) 0.75
Review Of Obesity And Atrial Fibrillation: Exploring The Paradox. J Atr Fibrillation (2015) 0.75
Differences in Short- and Long-Term Mortality Associated With BMI Following Coronary Revascularization. J Am Heart Assoc (2017) 0.75
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol (2009) 6.23
Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc (2013) 5.27
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.83
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol (2009) 2.83
Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus. Am J Cardiol (2012) 2.77
Omega-3 fatty acids for cardioprotection. Mayo Clin Proc (2008) 2.65
Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol (2013) 2.62
Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol (2007) 2.52
Run for your life ... at a comfortable speed and not too far. Heart (2012) 2.48
The obesity paradox, weight loss, and coronary disease. Am J Med (2009) 2.25
L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin Proc (2013) 2.10
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin (2010) 2.05
Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc (2012) 1.98
Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc (2009) 1.88
Physical activity promotion in the health care system. Mayo Clin Proc (2013) 1.83
Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol (2003) 1.81
Obesity and cardiovascular disease: the hippocrates paradox? J Am Coll Cardiol (2003) 1.80
Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox". Mayo Clin Proc (2010) 1.75
EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation (2012) 1.67
Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol (2012) 1.61
Intensive lipid intervention in the post-ENHANCE era. Mayo Clin Proc (2008) 1.55
Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J (2013) 1.53
Cardiac rehabilitation programs markedly improve high-risk profiles in coronary patients with high psychological distress. South Med J (2008) 1.50
Effects of muscular strength on cardiovascular risk factors and prognosis. J Cardiopulm Rehabil Prev (2012) 1.47
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care (2014) 1.47
The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention. Catheter Cardiovasc Interv (2009) 1.47
Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol (2002) 1.46
Triple versus dual antiplatelet therapy in acute coronary syndromes: adding cilostazol to aspirin and clopidogrel? Cardiology (2013) 1.44
Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol (2004) 1.44
Stopping stress at its origins. Hypertension (2007) 1.44
Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med (2007) 1.42
Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol (2011) 1.41
Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J Heart Lung Transplant (2009) 1.41
Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). Am J Cardiol (2013) 1.37
The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation (2013) 1.37
Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc (2009) 1.33
A prospective study of muscular strength and all-cause mortality in men with hypertension. J Am Coll Cardiol (2011) 1.33
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation (2014) 1.32
Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol (2006) 1.32
Dietary sodium restriction: take it with a grain of salt. Am J Med (2013) 1.30
Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis (2009) 1.27
Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction. Am J Cardiol (2006) 1.26
Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol (2003) 1.24
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation (2004) 1.24
Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nat Rev Cardiol (2009) 1.23
45-Year trends in women's use of time and household management energy expenditure. PLoS One (2013) 1.21
Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol (2007) 1.21
Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation. Arch Intern Med (2006) 1.21
Impact of obesity on the risk of heart failure and its prognosis. J Cardiometab Syndr (2008) 1.20
C-reactive protein and cardiovascular diseases--is it ready for primetime? Am J Med Sci (2009) 1.20
Heart rate variability characteristics in sedentary postmenopausal women following six months of exercise training: the DREW study. PLoS One (2008) 1.18
Ideal cardiovascular health and mortality: Aerobics Center Longitudinal Study. Mayo Clin Proc (2012) 1.18
Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox". J Am Coll Cardiol (2012) 1.16
Reducing psychosocial stress: a novel mechanism of improving survival from exercise training. Am J Med (2009) 1.15
Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J (2004) 1.12
The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc (2012) 1.11
Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc (2006) 1.10
Maternal inactivity: 45-year trends in mothers' use of time. Mayo Clin Proc (2013) 1.10
Cardiac rehabilitation and exercise training in secondary coronary heart disease prevention. Prog Cardiovasc Dis (2011) 1.10
Protective role of resting heart rate on all-cause and cardiovascular disease mortality. Mayo Clin Proc (2013) 1.10
Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant (2006) 1.10
Peak exercise oxygen pulse and prognosis in chronic heart failure. Am J Cardiol (2004) 1.10
The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med (2008) 1.09
Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin Proc (2013) 1.09
The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus. Mayo Clin Proc (2009) 1.08
Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease. Am Heart J (2002) 1.07
Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs. Am J Cardiol (2009) 1.06
Of mice and men: atrial fibrillation in veteran endurance runners. J Am Coll Cardiol (2013) 1.06
Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol (2004) 1.05
Validation of a novel protocol for calculating estimated energy requirements and average daily physical activity ratio for the US population: 2005-2006. Mayo Clin Proc (2013) 1.05
A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure. Heart Fail Rev (2013) 1.05
Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev (2011) 1.04
The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev (2008) 1.04
Body composition and coronary heart disease mortality--an obesity or a lean paradox? Mayo Clin Proc (2011) 1.02